Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review
Open Access
- 11 January 2022
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 11 (1) , 83
Abstract
Chronic bacterial prostatitis is increasingly difficult to treat due to rising antimicrobial resistance limiting oral treatment options. In this case series, 11 men with CBP (including patients with urological comorbidities) due to multi-resistant E. coli were treated with once-daily ceftriaxone intravenously for 6 weeks. Nine patients were clinically cured at 3 months follow up. No early withdrawal of medication due to side effects occurred. A literature review was conducted to describe the prostate pharmacokinetics of ceftriaxone and its use in prostatic infection. In conclusion, ceftriaxone can be considered an appropriate treatment of chronic bacterial prostatitis.Keywords
This publication has 27 references indexed in Scilit:
- Reduction in Hospital Admissions With the Addition of Prophylactic Intramuscular Ceftriaxone Before Transrectal Ultrasonography–guided Prostate BiopsiesUrology, 2015
- Antimicrobial therapy for chronic bacterial prostatitisCochrane Database of Systematic Reviews, 2013
- Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical UseInterdisciplinary Perspectives on Infectious Diseases, 2012
- Outpatient parenteral antimicrobial therapy with ceftriaxone, a reviewInternational Journal of Clinical Pharmacy, 2012
- Treatment of Bacterial ProstatitisClinical Infectious Diseases, 2010
- Management of bacterial prostatitis: what’s new?BJU International, 2008
- Semen and urine culture in the diagnosis of chronic bacterial prostatitisInternational braz j urol, 2008
- Laboratory Diagnosis of Urinary Tract Infections in Adult PatientsClinical Infectious Diseases, 2004
- The use of ceftriaxone in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P)Infection, 1994
- Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract InfectionClinical Infectious Diseases, 1992